Efficacy and Safety of Rifaximin Treatment for Reducing the Risk of Overt Hepatic Encephalopathy by Baseline Hepatic Impairment

被引：0
|
作者：
Flamm, Steven L. [1 ]
Bajaj, Jasmohan S. [2 ,3 ]
Heimanson, Zeev [4 ]
Neff, Guy [5 ]
机构：
[1] Northwestern Feinberg, Sch Med, Chicago, IL USA
[2] Virginia Commonwealth Univ, Richmond, VA USA
[3] McGuire VA Med Ctr, Richmond, VA USA
[4] Salix Pharmaceut, Bridgewater, NJ USA
[5] Florida Digest Hlth Specialists, Florida Res Inst, Lakewood Ranch, FL USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2018年 / 113卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
829
引用
收藏
页码：S458 / S460
页数：3
相关论文
共 50 条
  • [21] RIFAXIMIN IN THE TREATMENT OF CHRONIC HEPATIC-ENCEPHALOPATHY - RESULTS OF A MULTICENTER STUDY OF EFFICACY AND SAFETY
    FESTI, D
    MAZZELLA, G
    ORSINI, M
    SOTTILI, S
    SANGERMANO, A
    BASSI, SL
    PARINI, P
    FERRIERI, A
    FALCUCCI, M
    GROSSI, L
    MARZIO, L
    RODA, E
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1993, 54 (05): : 598 - 609
  • [22] Treatment of Overt Hepatic Encephalopathy
    Sussman, Norman L.
    CLINICS IN GERIATRIC MEDICINE, 2015, 31 (03) : 551 - 563
  • [23] EVALUATION OF EFFICACY OF RIFAXIMIN IN THE TREATMENT OF HEPATIC ENCEPHALOPATHY IN PATIENTS WITH CIRRHOSIS
    Habib, Hafsa
    Nayab, Dur-e
    Hayat, Zafar
    Jamil, Shahid
    Khan, Habibullah
    GOMAL JOURNAL OF MEDICAL SCIENCES, 2016, 14 (01): : 37 - 40
  • [24] The clinical efficacy of rifaximin in the treatment or hepatic encephalopathy (comparison with lactulose).
    Song, KH
    Lee, KS
    Kim, MH
    Paik, YH
    Moon, BS
    Yoon, SH
    Han, KH
    Chon, CY
    Moon, YM
    HEPATOLOGY, 2000, 32 (04) : 407A - 407A
  • [25] Efficacy and safety of rifaximin for the prophylaxis of hepatic encephalopathy: A meta-analysis
    Huang, Ji
    Cheng, Cong
    Li, Yong
    Liu, Yongqi
    Liu, Youshun
    MEDICINE, 2025, 104 (05)
  • [26] Role of rifaximin in the treatment of hepatic encephalopathy
    Sanchez-Delgado, Jordi
    Miquel, Mireia
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2016, 39 (04): : 282 - 292
  • [27] RIFAXIMIN PLUS LACTULOSE VERSUS LACTULOSE ALONE FOR REDUCING THE RISK OF OVERT HEPATIC ENCEPHALOPATHY RECURRENCE: A POOLED SUBGROUP ANALYSIS
    Sanyal, Arun J.
    Brown, Robert S., Jr.
    Sundaram, Vinay
    Heimanson, Zeev
    Israel, Robert J.
    Bajaj, Jasmohan S.
    HEPATOLOGY, 2022, 76 : S1186 - S1187
  • [28] OUTCOMES OF RIFAXIMIN PLUS LACTULOSE VERSUS LACTULOSE ALONE IN TREATMENT OF OVERT HEPATIC ENCEPHALOPATHY
    Gill, M. L.
    Niaz, T.
    Aziz, H.
    Khan, S.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S215 - S215
  • [29] Efficacy of long-term rifaximin treatment for hepatic encephalopathy in the Japanese
    Nishida, Shinya
    Hamada, Koichi
    Nishino, Noriyuki
    Fukushima, Daizo
    Koyanagi, Ryota
    Horikawa, Yoshinori
    Shiwa, Yoshiki
    Saitoh, Satoshi
    WORLD JOURNAL OF HEPATOLOGY, 2019, 11 (06) : 531 - 541
  • [30] Efficacy of long-term rifaximin treatment for hepatic encephalopathy in the Japanese
    Shinya Nishida
    Koichi Hamada
    Noriyuki Nishino
    Daizo Fukushima
    Ryota Koyanagi
    Yoshinori Horikawa
    Yoshiki Shiwa
    Satoshi Saitoh
    World Journal of Hepatology, 2019, (06) : 531 - 541
12345